Claudia Haydée González-De la Rosa

Randomized Phase II Trial of All-<i>Trans</i>-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer

Óscar Arrieta, Claudia Haydée González-De la Rosa, Elena Aréchaga-Ocampo et al. · Journal of Clinical Oncology · 2010 · 124 citations · Full text

Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis

Óscar Arrieta, Benjamín Pineda, Patricia Guevara-Salazar et al. · British Journal of Cancer · 2008 · 83 citations · Full text

New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR

Isidro X. Perez‐Añorve, Claudia Haydée González-De la Rosa, Ernesto Soto‐Reyes et al. · Molecular Oncology · 2019 · 66 citations · Full text

Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells

Alejandro García-Regalado, Miguel Vargas, Alejandro Garcı́a-Carrancá et al. · Molecular Cancer · 2013 · 50 citations · Full text

Tumor suppressor miR-29c regulates radioresistance in lung cancer cells

Elena Aréchaga-Ocampo, César López‐Camarillo, Nicolás Villegas‐Sepúlveda et al. · Tumor Biology · 2017 · 49 citations · Full text

Tumor Biology, Radiation Medicine, Oncology +15